‘Razor blade' sore throats? What to know about latest COVID variant
The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: 'razor blade throat' COVID.
That's because the variant — NB.1.8.1. or 'Nimbus' — may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries.
Other COVID-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell.
Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it.
Here's where the variant causing 'razor blade throat' is spreading
The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May.
Story continues below advertisement
Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York.
2:01
Health-care workers urge Alberta to halt plan limiting free COVID-19 vaccines
You aren't likely to get sicker from this variant than others
Get weekly health news
Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up
By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy
Not so far, anyway.
The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants.
COVID-19 vaccines are effective against the Nimbus variant
Yes.
The WHO has designated Nimbus as a 'variant under monitoring' and considers the public health risk low at the global level. Current vaccines are expected to remain effective.
Story continues below advertisement
Health Secretary Robert F. Kennedy Jr. announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women — a move immediately questioned by public health experts.
—AP Health Writer Carla Johnson contributed to this story.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Toronto Star
2 hours ago
- Toronto Star
What to know about the COVID variant that may cause ‘razor blade' sore throats
The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: 'razor blade throat' COVID. That's because the variant — NB.1.8.1. or 'Nimbus' — may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries. Canada Explainer The 'razor blade' sore throat: What to know about the new COVID-19 variant that's spreading Asma Sahebzada Other COVID-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell. ARTICLE CONTINUES BELOW Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it. Here's where the variant causing 'razor blade throat' is spreading The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May. Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York. You aren't likely to get sicker from this variant than others Not so far, anyway. The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants. COVID-19 vaccines are effective against the Nimbus variant Yes. The WHO has designated Nimbus as a 'variant under monitoring' and considers the public health risk low at the global level. Current vaccines are expected to remain effective. Health Secretary Robert F. Kennedy Jr. announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women — a move immediately questioned by public health experts. ARTICLE CONTINUES BELOW ARTICLE CONTINUES BELOW ___ AP Health Writer Carla Johnson contributed to this story. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Science and Educational Media Group and the Robert Wood Johnson Foundation. The AP is solely responsible for all content.
CTV News
6 hours ago
- CTV News
Northern Health ramping up vaccine availability as measles cases may be undercounted
Confirmed measles infections continue to grow across the country, including in B.C., where more suspected cases have been found.
Global News
9 hours ago
- Global News
As B.C.'s over-50 population grows, advocates want the shingles vaccine covered
Seniors' advocates are calling on the province to pay for the shingles vaccine. Currently, the shingles vaccine is not covered under B.C. MSP but it is funded in some other provinces for certain age groups. The vaccine is recommended for adults aged 50 and older and according to studies is more than 90 per cent effective. Almost 40 per cent of B.C.'s population is over 50 and physicians warn that shingles, which is a debilitating condition itself, can lead to other, more serious health concerns. Victoria-based physician, Dr. Wayne Ghesquiere, said any barriers to vaccination should be removed. Get weekly health news Receive the latest medical news and health information delivered to you every Sunday. Sign up for weekly health newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy 'Removing any obstacle to getting the vaccine, sometimes cost is an obstacle, the number-one obstacle is actually a health-care provider recommending the vaccine and educating the public what are the risks of shingles and the benefits of it,' he said. Story continues below advertisement 'That's the number-one obstacle. Patients just aren't aware of the risks that they have.' 1:53 N.S. to cover cost of shingles vaccine for residents 65 and older starting end of May Two doses of the vaccine are usually required and in B.C., the cost is approximately $150 per dose. B.C. Health Minister Josie Osborne said they are always open to discussions about what should be funded by the government. 'I think that's an excellent question in terms of the impact shingles as a disease can have on people and their health,' she said. Seniors' advocates would like to see the vaccine covered under MSP. 'The only thing standing in the way of British Columbia providing it is having the political will to do so,' Laura Tamblyn Watts, founder and CEO of CanAge said. Story continues below advertisement 'And making sure that we are standing up for science.'
